The Diagnostic Accuracy of Ultrasound in Assessment of Myometrial Invasion in Endometrial Cancer: Subjective Assessment versus Objective Techniques
Table 1
Demographic and clinical characteristics of 210 women with histologically confirmed endometrial cancer.
Characteristic
Value
Age (years)
66 (53; 83)
Body mass index (kg/m2)
30 (21; 47)
Postmenopausal
193 (91.9)
Family history of breast and/or gynecological cancer
23 (10.9)
Current high/medium potency hormone use1
12 (5.7)
Current low potency estrogen use2
1 (0.5)
Current tamoxifen use
2 (0.9)
FIGO stage3
IA
108 (51.4)
IB
56 (26.7)
II
18 (8.6)
IIIA
6 (2.9)
IIIB
0 (0.0)
IIIC1
8 (3.8)
IIIC2
8 (3.8)
IVA
0 (0.0)
IVB
6 (2.9)
Histological subtype and grade
Endometrioid adenocarcinoma, Grade 1
100 (47.6)
Endometrioid adenocarcinoma, Grade 2
59 (28.1)
Endometrioid adenocarcinoma, Grade 3
26 (12.4)
Nonendometrioid adenocarcinoma
25 (11.9)
Data are given as median (5th percentile; 95th percentile) for continuous variables; (%) for categorical variables. /dermal estradiol in combination with sequential or continuous progesterone. /vaginal estriol or vaginal estradiol. Federation of Gynecology and Obstetrics (FIGO) 2009 staging criteria.